Last updated on November 2019

A 28 Day Parallel Group Study to Assess the Effects of RDN-929


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy
  • Age: Between 55 - 85 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adult males or postmenopausal or surgically sterile females age 55 - 85 years old.
  • Healthy as determined by the Investigator, based on a medical evaluation including medical history, physical examination, neurological examination, laboratory tests and ECG recording

Exclusion Criteria:

  • Any history of major psychiatric disorders, including substance use disorders, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria
  • Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 1.5 times the upper limit of normal (ULN)
  • A clinically significant abnormality on physical examination, neurological examination, ECG, or laboratory evaluations
  • A clinically significant vital signs abnormality, as judged by the principal investigator

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.